Jiangxi Synergy Pharmaceutical (300636.SZ) has obtained the European Pharmacopoeia Certification.
Tonghe Pharmaceutical (300636.SZ) announces that the company recently received the European Medicines Quality Management Agency (EDQM) certification...
Jiangxi Synergy Pharmaceutical (300636.SZ) announced that the company recently received the updated European Pharmacopoeia Compliance Certificate (CEP) for the active pharmaceutical ingredient Tenofovir Disoproxil Fumarate from the European Directorate for the Quality of Medicines (EDQM). The main reason for this update is the addition of a new production workshop, with the certification scope covering Tenofovir Disoproxil Fumarate. The updated certificate will take effect from September 12, 2025.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
